Nilvadipine Is Effective for Chronic Schizophrenia in a Double-Blind Placebo-Controlled Study
作者:
Kazuo Yamada,
Shigenobu Kanba,
Iyoko Ashikari,
Kimio Ohnishi,
Gohei Yagi,
Masahiro Asai,
期刊:
Journal of Clinical Psychopharmacology
(OVID Available online 1996)
卷期:
Volume 16,
issue 6
页码: 437-439
ISSN:0271-0749
年代: 1996
出版商: OVID
数据来源: OVID
摘要:
We investigated the efficacy of nilvadipine, a calcium channel inhibitor, for psychiatric symptoms and tardive dyskinesia in 30 patients with chronic schizophrenia in a placebo-controlled double-blind crossover study. The total scores of the Brief Psychiatric Rating Scale decreased significantly when the patients were on nilvadipine compared with placebo. Improvement was particularly significant in emotional withdrawal and uncooperativeness. Nilvadipine was not effective, however, for tardive dyskinesia. No adverse effects, such as hypotension, occurred. (J Clin Psychopharmacol 1996;16:437-439).
返 回